Eleftheria Chorti

Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival

D. Schadendorf, P. Jansen, S. Ugurel, 2022, Cancers.

Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology.

D. Schadendorf, P. Jansen, E. Livingstone, 2021, European journal of cancer.

Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

D. Schadendorf, S. Ugurel, L. Umutlu, 2022, Cancer Imaging.

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG

M. Weichenthal, J. Utikal, C. Berking, 2020, Journal for ImmunoTherapy of Cancer.

Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.

D. Schadendorf, S. Ugurel, A. Roesch, 2020, European journal of cancer.

TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy.

M. Weichenthal, J. Utikal, D. Schadendorf, 2021, European journal of cancer.